Applying the LV-gRNA/dCas9-DNMT3A system to human induced pluripotent stem cell (hiPSC)-derived dopaminergic (DA) neurons from a patient with PD with SNCA triplication resulted in downregulation of SNCA RNA and protein governed by targeted methylation at the intron 1 region. Here, DNMT3A is linked to Parkinson disease.